Literature DB >> 9568524

The epidemiology of erectile dysfunction and its risk factors.

A Bortolotti1, F Parazzini, E Colli, M Landoni.   

Abstract

Erectile dysfunction (ED) affects millions of men throughout the world. The literature is ample, but an accurate estimate of its prevalence is still difficult since figures mainly refer to the USA, and are based mostly on small selected samples of people. Caution must anyway be used in comparing data from studies conducted in the past because of possible differences in the definition and classification of ED. Many factors are believed to contribute to the development and maintenance of ED. The influence of age and of several medical conditions (diabetes, vascular disease, and chronic diseases such as hepatic failure, renal failure and dialysis) is well defined. Also well documented is the role of some drug groups, whereas the role of other pharmacological agents is still controversial because of the frequent coexistence of other pathological conditions or concomitant exposure to other drugs. Less well defined and sometimes controversial is the role of risk factors mainly related to life-style such as cigarette smoking, alcoholism, total cholesterol levels and certain types of trauma. This paper reviews the main data on the epidemiology of ED and some related risk factors.

Entities:  

Mesh:

Year:  1997        PMID: 9568524     DOI: 10.1046/j.1365-2605.1998.00081.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  20 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

2.  Role of exercise treadmill testing in the management of erectile dysfunction: a joint cardiovascular/erectile dysfunction clinic.

Authors:  H Solomon; J Man; E Martin; G Jackson
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

3.  The difference of heart rate recovery between males with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar; Ahmet Haciislamoglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

4.  Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil.

Authors:  O Özdabakoğlu; S Güllülü; S Sağ; T Şentürk; H Kiliçarslan; A Tütüncü; M Keçebaş; I Baran; A Aydinlar
Journal:  Int J Impot Res       Date:  2016-12-08       Impact factor: 2.896

Review 5.  [A discussion of the differential diagnosis of the impaired erection].

Authors:  G A Schaefer; C J Ahlers
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

Review 6.  Management of erectile dysfunction in hypertension: Tips and tricks.

Authors:  Margus Viigimaa; Charalambos Vlachopoulos; Antonios Lazaridis; Michael Doumas
Journal:  World J Cardiol       Date:  2014-09-26

7.  Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

Authors:  B M Hoffman; A Sherwood; P J Smith; M A Babyak; P M Doraiswamy; A Hinderliter; J A Blumenthal
Journal:  Int J Impot Res       Date:  2009-09-24       Impact factor: 2.896

8.  Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction.

Authors:  Ahmed M Emarah; Shawky M El-Haggar; Ihab A Osman; Abdel Wahab S Khafagy
Journal:  Clin Ophthalmol       Date:  2010-09-20

9.  Prolactinoma in a diabetic dialysis patient with erectile dysfunction: a difficult differential diagnosis.

Authors:  Giorgina B Piccoli; Francesca Bermont; Andrea Magnano; Giorgio Soragna; Massimo Terzolo
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 10.  Treatment of erectile dysfunction in patients with cardiovascular disease : guide to drug selection.

Authors:  Graham Jackson
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.